Funder: The Mark Foundation for Cancer Research

Due Dates: January 8, 2025 (Glioblastoma RFP LOI) | September 3, 2025 (Endeavor Award LOI) | January 1, 2026 (Endeavor Award full application)

Funding Amounts: $3,000,000 per award over 3 years; typically 2 awards per cycle

Summary: Supports multidisciplinary teams to collaboratively address major challenges in cancer prevention, diagnosis, and treatment through integrative research.

Key Information: Institutional submission limits apply; teams must include 3+ investigators from non-profit academic/research institutions.